KLRA is Kailera Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $16.23. Market cap: $2.10B.
Stock snapshot
| Price | $16.23 |
| Market cap | $2.10B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About KLRA
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
Related non-dividend companies
Other non-dividend stocks investors research alongside KLRA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is KLRA's current stock price?
KLRA (Kailera Therapeutics, Inc.) is currently trading at $16.23.
Does KLRA pay a dividend?
KLRA (Kailera Therapeutics, Inc.) does not currently pay a regular dividend.
Track KLRA in DiviDrip
Add KLRA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search KLRA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.